<?xml version="1.0" encoding="UTF-8"?>
<abstract abstract-type="author-highlights" id="ab0010">
 <title>Highlights</title>
 <p>
  <list list-type="simple" id="l0005">
   <list-item id="li0005">
    <label>•</label>
    <p id="p0005">Passive antibody transfer has been used to treat individuals infected with various microorganisms.</p>
   </list-item>
   <list-item id="li0010">
    <label>•</label>
    <p id="p0010">One modality of passive antibody transfer is convalescent plasma, which is collected from recovered patients to be transfused into sick patients.</p>
   </list-item>
   <list-item id="li0015">
    <label>•</label>
    <p id="p0015">Historical accounts of the use of convalescent plasma in the management and treatment of viral infections have been published with varying reports on efficacy.</p>
   </list-item>
   <list-item id="li0020">
    <label>•</label>
    <p id="p0020">The majority of data comes from cases reports and case series with few high-quality nonrandomized or randomized control trials published.</p>
   </list-item>
   <list-item id="li0025">
    <label>•</label>
    <p id="p0025">The current SARS-CoV-2 pandemic offers another occasion to assess the potential clinical efficacy of convalescent plasma in the prophylaxis and treatment of disease.</p>
   </list-item>
  </list>
 </p>
</abstract>
